Yes. It's going to give biomarkers more credence in the approval process.
But, the scientists are saying that these new "guidelines" are a mess - vague and leaving too much room for speculation as to what counts and what doesn't.
(0)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links